Dr. Reddy's Labs Launches Aripiprazole Tablets, USP Tablets In U.S.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) said that it has launched Aripiprazole tablets, USP, in 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, a therapeutic equivalent generic version of Abilify or aripiprazole tablets in the United States market approved by the U.S. Food & Drug Administration or USFDA.

The Abilify brand and generic tablets had U.S. sales of approximately $3.1 billion MAT for the most recent twelve months ending in August 2016 according to IMS Health.

Dr. Reddy's Aripiprazole tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg are available in bottle count sizes of 30.